Company

Merida Biosciences, Inc.

Merida Biosciences develops therapies for autoimmune and allergic disorders.

About

Merida Biosciences develops precision therapies for antibody-driven autoimmune and allergic diseases. Founded in 2022, the company is based in Cambridge, US. In April 2025, it raised USD 121.00 mn in Series A funding co-led by BVF Partners, Bain Capital, GV, Perceptive Advisors and Third Rock Ventures.

2Funding rounds

4Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in